Patent · US Active

Methods for diagnosing IDH-mutant cell proliferation disorders

US10711314B2 · kind B2 · utility

0Cited by

25References

8Claims

0Family size

Assignee

Agios Pharmaceuticals, Inc. · US

Inventors

Leonard Luan C. Dang · Hancock, US
Stefan Gross · Superior, US
Hyun Gyung Jang · Waltham, US
Shengfang Jin · Newton, US
Shin-San Michael Su · Newton, US
Craig B. Thompson · Yeadon, US

Key dates

Filing date	Apr 26, 2018
Grant date	Jul 14, 2020
Priority date	—
Expiry date	Apr 26, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/156
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods of diagnosing subjects having a cell proliferation-related disorder or suspected of having a cell proliferation-related disorder associated with mutant IDH enzymes with 2HG neoactivity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.